Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.56 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | NQO1 | P15559 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8507803 | 0.88 | MAPT (0.66) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL8017897 | 0.88 | MAPT (0.66) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL5642944 | 0.84 | TDP1 (0.47) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL5076662 | 0.83 | MAPT (0.68) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| Morpholine SCHEMBL11044415 | 0.83 | SMN1; SMN2 (0.46) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL5952240 | 0.83 | MEN1 (0.66) | NPC1HSD17B10MEN1KMT2AAPOBEC3G | |
| SCHEMBL30646246 | 0.83 | MEN1 (0.66) | NPC1HSD17B10MEN1KMT2AAPOBEC3G | |
| SCHEMBL27457236 | 0.82 | MAPT (0.50) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL27477548 | 0.82 | HSD17B10 (0.53) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 | |
| SCHEMBL30678626 | 0.81 | MAPT (0.69) | NPC1HSD17B10USP2RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115206689-B | Graphene modified material and preparation method thereof | 浙江理工大学 | 2024-02-09 | — | — | CN | claimed |
| US-4288362-A | Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | claimed |
| JP-7196967-A | — | — | None | — | — | JP | disclosed |
| US-20250177359-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | OULUN YLIOPISTO (FI) | 2025-06-05 | — | — | US | disclosed |
| US-20250171582-A1 | CURING AGENT COMPOSITION FOR THERMOSETTING RESIN, EPOXY RESIN COMPOSITION, AND FIBER-REINFORCED COMPOSITE MATERIAL | TEIJIN LIMITED (JP) | 2025-05-29 | — | — | US | disclosed |
| WO-2024074814-A9 | COMPOSITION COMPRISING A FUNCTIONALISED DYE AND A DIALLYLAMINE COMONOMER AND USE THEREOF | SUBLINO LIMITED (GB) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025100475-A1 | COMPOSITION FOR IMAGE RECORDING AND METHOD FOR PRODUCING SAME | キヤノン株式会社 | 2025-05-15 | — | — | WO | disclosed |
| EP-4469046-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | Oulun Yliopisto (FI) | 2024-12-04 | — | — | EP | disclosed |
| EP-4471073-A1 | CURING AGENT COMPOSITION FOR THERMOSETTING RESIN, EPOXY RESIN COMPOSITION, AND FIBER-REINFORCED COMPOSITE MATERIAL | Teijin Limited (JP) | 2024-12-04 | — | — | EP | disclosed |
| CN-117486747-B | Synthesis method of N- (4-amino-2, 5-diethoxyphenyl) benzamide | 安徽申兰华色材股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-3709081-B1 | CONDUCTIVE POLYMER COMPOSITION, COATED PRODUCT AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-3989450-A | DYEING AND PRINTING SYNTHETIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3987056-A | DISPROPORTIONATION OF N-ARYL-1,2,3,6-TETRAHYDROPHTHALIMIDES | PHILLIPS PETROLEUM COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3980677-A | Anthraquinone dyestuffs containing sulphonic acid groups | BAYER AKTIENGESELLSCHAFT (DT) | 1976-09-14 | — | — | US | disclosed |
| US-3971770-A | Disulfimide disazo dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3971769-A | NATURAL AND SYNTHETIC POLYAMIDES, CELLULOSE ACETATE | CROMPTON & KNOWLES CORPORATION (US) | 1976-07-27 | — | — | US | disclosed |
| US-3957749-A | WATER-INSOLUBLE MONOAZO PYRIDINE DYES | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
| US-3956267-A | Indole-containing disazo dyestuffs having a sulfatoalkyleneoxy-substituent | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3945992-A | DISAZO DYES FOR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
| US-3932378-A | Sulfonated disazo dyestuffs containing an ether group | CIBA-GEIGY AG (CH) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177359-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | NAMPT, NADK, NQO1 | NPC1 2863/4885HSD17B10 668/4885USP2 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.